Long-Term Management of Moderate-to-Severe Plaque Psoriasis: Maintenance of Treatment Success Following Cessation of Fixed Combination Halobetasol Propionate 0.01% And Tazarotene 0.045% (HP/TAZ) Lotion

Main Article Content

Lina Stein Gold
Mark G Lebwohl
Neal Bhatia
Tina Lin
Radhakrishnan Pillai

Keywords

psoriasis, tazarotene, halobetasol

Abstract

Abstract not available.

References

1. Nestle FO, et al. N Engl J Med. 2009;361(5):496-509.

2. Cohen SN, et al. Clin Exp Dermatol. 2012;37 Suppl 1:13-8.

3. Kim WB, et al. Can Fam Physician. 2017;63(4):278-285.

4. Uva L, et al. Int J Endocrinol. 2012;2012:561018.

5. Svendsen, MT, et al. J Dermatolog Treat. 2019:1-10.

6. Belinchón I, et al. Patient Prefer Adherence. 2016;10:2357-2367.

Most read articles by the same author(s)

1 2 3 4 5 > >>